These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36697247)

  • 21. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.
    Hohman TJ; Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Bennett DA; Schneider JA; Jefferson AL;
    JAMA Neurol; 2018 Aug; 75(8):989-998. PubMed ID: 29801024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2007 Feb; 113(2):107-17. PubMed ID: 17089134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MAPT H1 haplotype is associated with tangle-predominant dementia.
    Santa-Maria I; Haggiagi A; Liu X; Wasserscheid J; Nelson PT; Dewar K; Clark LN; Crary JF
    Acta Neuropathol; 2012 Nov; 124(5):693-704. PubMed ID: 22802095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
    Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
    J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
    Jellinger KA
    J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of APOE with tau-tangle pathology with and without β-amyloid.
    Farfel JM; Yu L; De Jager PL; Schneider JA; Bennett DA
    Neurobiol Aging; 2016 Jan; 37():19-25. PubMed ID: 26481403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes is related to cerebral infarction but not to AD pathology in older persons.
    Arvanitakis Z; Schneider JA; Wilson RS; Li Y; Arnold SE; Wang Z; Bennett DA
    Neurology; 2006 Dec; 67(11):1960-5. PubMed ID: 17159101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.
    Mold MJ; O'Farrell A; Morris B; Exley C
    J Alzheimers Dis; 2020; 78(1):139-149. PubMed ID: 32925074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.
    Näslund J; Haroutunian V; Mohs R; Davis KL; Davies P; Greengard P; Buxbaum JD
    JAMA; 2000 Mar 22-29; 283(12):1571-7. PubMed ID: 10735393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology.
    Replogle JM; Chan G; White CC; Raj T; Winn PA; Evans DA; Sperling RA; Chibnik LB; Bradshaw EM; Schneider JA; Bennett DA; De Jager PL
    Ann Neurol; 2015 Mar; 77(3):469-77. PubMed ID: 25545807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
    Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.
    Thal DR; von Arnim CA; Griffin WS; Mrak RE; Walker L; Attems J; Arzberger T
    J Neural Transm (Vienna); 2015 Jul; 122(7):1007-18. PubMed ID: 25556950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Early-Life Cognitive Enrichment With Alzheimer Disease Pathological Changes and Cognitive Decline.
    Oveisgharan S; Wilson RS; Yu L; Schneider JA; Bennett DA
    JAMA Neurol; 2020 Oct; 77(10):1217-1224. PubMed ID: 32597941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Education modifies the relation of AD pathology to level of cognitive function in older persons.
    Bennett DA; Wilson RS; Schneider JA; Evans DA; Mendes de Leon CF; Arnold SE; Barnes LL; Bienias JL
    Neurology; 2003 Jun; 60(12):1909-15. PubMed ID: 12821732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex differences in the clinical manifestations of Alzheimer disease pathology.
    Barnes LL; Wilson RS; Bienias JL; Schneider JA; Evans DA; Bennett DA
    Arch Gen Psychiatry; 2005 Jun; 62(6):685-91. PubMed ID: 15939846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.